Shares of Roka Bioscience, Inc. (NASDAQ:ROKA) shot up 21.7% on Thursday . The company traded as high as $2.38 and last traded at $2.19. 6,856,108 shares traded hands during trading, an increase of 1,059% from the average session volume of 591,454 shares. The stock had previously closed at $1.80.
The company has a 50 day moving average price of $1.05 and a 200 day moving average price of $2.46. The firm’s market capitalization is $10.97 million.
In related news, major shareholder Orbimed Advisors Llc sold 127,601 shares of the business’s stock in a transaction on Wednesday, September 27th. The stock was sold at an average price of $0.98, for a total transaction of $125,048.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last 90 days, insiders have sold 894,570 shares of company stock valued at $741,435. 29.20% of the stock is owned by company insiders.
An institutional investor recently bought a new position in Roka Bioscience stock. AWM Investment Company Inc. acquired a new stake in shares of Roka Bioscience, Inc. (NASDAQ:ROKA) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 132,297 shares of the medical research company’s stock, valued at approximately $352,000. AWM Investment Company Inc. owned 2.64% of Roka Bioscience as of its most recent SEC filing. 66.51% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “Roka Bioscience, Inc. (ROKA) Shares Up 21.7%” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/10/12/roka-bioscience-inc-roka-shares-up-21-7.html.
Roka Bioscience Company Profile
Roka Bioscience, Inc is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications.
Receive News & Ratings for Roka Bioscience Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roka Bioscience Inc. and related companies with MarketBeat.com's FREE daily email newsletter.